An interventional study of breastfeeding and oral sucrose in Pain and Breast Feeding, sponsored by Stanford University. Completed. Open to participants aged 24 Hours to 48 Hours, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-05.
Sponsored by Stanford University · Not applicable, Interventional, and Treatment
Among 17 studies testing sucrose in Pain — none open to participants now, none under way, none of them phase 3. Sucrose · Pain.
Among the 17 studies testing sucrose in Pain, this one is the 6th largest by enrollment, is the only one that started in 2014, is one of 6 with no phase, and was the 16th registered.
10,060 studies on the registry are indexed under Pain; 1,651 are open to participants now.
Browse Pain studies →None of the 17 studies testing sucrose in Pain is open now. The open studies under Pain, anywhere →
No approval found in the FDA or EMA files read. How studies give it is on its page →
Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.
This study: 24 Hours to 48 Hours · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 7 · Phase 4 2
First in 2003; this study’s year is marked. 1 started in 2014.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 236 is above the median of 66 across 8,497 interventional studies indexed under Pain.
Median enrollment 120 across the 17 interventional studies. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 17 has an industry lead sponsor. The 10 most frequent:
Stanford University is the lead sponsor of 2,170 studies on the registry; 433 are open to participants now.
Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.
59 studies in Pain by Stanford University: 4 open now, 6 under way, none of them phase 3. Of 44 finished, 19 (43%) have results posted.
Among the 59 studies in Pain by Stanford University, this one is the 5th largest by enrollment of the 49 interventional ones that give a count, is one of 5 that started in 2014, is one of 39 with no phase, and was the 26th registered.
Stanford University’s Pain studies by the year they started, since 2004.
None of the studies under way reaches primary completion within a year.
Among the 17 studies testing sucrose in Pain, from their registry updates:
Nothing recorded among them since 2026-09-25.
Among Stanford University’s 59 in Pain:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to compare the analgesic effects of four non-pharmacological interventions: skin-to-skin contact, breastfeeding, oral sucrose and nonnutritive sucking in newborns receiving a heel lance procedure.
This is an randomized control clinical study. study population is healthy term newborns.Patients were identified by chart review and consent was received by nurse researcher. Newborns were randomized into either the control group who received no pain intervention or the intervention group who received one of four non-pharmacological pain interventions: skin to skin contact, breastfeeding, oral sucrose, and nonnutritive sucking.
A heel lance for newborn screen blood sampling was selected as a study procedure and performed by a hospital technician following standard protocol. Pain scoring was assessed by two research nurses after the hell lance and through the procedure. Neonatal Pain, Agitation and Sedation Scale (NPASS) was selected as a pain assessment tool for this study.
The average pain score from two research nurses were used for statistical analysis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Newborns received no pain interventions during the procedure
Newborns were breastfed during the procedure
Behavioral: breastfeeding
Newborns were given oral sucrose during the procedure
Dietary Supplement: oral sucrose
Newborns were placed in direct contact with their mothers during the procedure
Behavioral: Skin-to-Skin contact
Newborns were given a pacifier to suck on during the procedure
Behavioral: Non-nutritive sucking
Newborns were breastfed during the procedure
Newborns were given oral sucrose during the procedure
Newborns were placed in direct contact with their mothers during the procedure
newborns were given a pacifier to suck on during the procedure
Also known as: Pacifier
Decrease in Neonatal Pain, Agitation and Sedation Scale (NPASS) scores for newborns receiving non-pharmacologic interventions
Neonatal Pain, Agitation and Sedation Scale (NPASS) measures both behavioral and physiological components of pain by evaluating five key elements, and scores pain from 0-10 (Patricia A. Hummel, 2004). The assessment criteria are crying irritability, behavior state, facial expression, extremities tone, and vital signs.
Time frame: 12 month
No study locations are listed for this record.
Plan to share: Yes
No publications or documents are linked to this record.
Ran from Nov 2014 to primary completion in Sep 2015, 10 months.
Of 3,734 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 10 months is close to that.
Counting every sponsor, half of 3,833 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Sucrose